Vasopressin
FDA-approved vasopressin for shock (Vasostrict) and related uses.
Ref $ —reference only
VasopressinFDA-approvedWhat it's for
FDA-approved vasopressin for shock (Vasostrict) and related uses.
What it's for
Vasopressin (arginine vasopressin) is a nine–amino-acid peptide hormone.
What it does for the body
IV (into a vein) formulations treat blood-vessel–widening shock (e.g., septic shock) to raise blood pressure; other historical/labeled uses include diabetes insipidus (a water-balance condition) and certain bleeding contexts depending on product. People often hear about it through clinics, forums, or news — this guide sticks to what published research and regulators actually support.
What it targets
It targets V1a receptors on blood vessels (tightening them to raise blood pressure) and V2 receptors in the kidney (helping the body hold onto water). Those two pathways explain its uses in shock and water-balance conditions, depending on the product label.
Research context
Bottom line for readers: Vasopressin has a defined FDA-approved story. Use the citations tab to open labels and trial registries, and treat anything beyond the label as unverified.
Studied for (literature interest)
- Heart research interest (educational tag)
Cautions (educational)
- Educational only — not medical advice.
- DrPep does not offer medical consultations, dosing guidance, suppliers, or peptide sales.
Citations / starters
- FDA search: Vasopressin — FDA.gov search
- ClinicalTrials.gov search: Vasopressin — U.S. clinical trials registry
- Drugs@FDA search: Vasopressin — FDA drug database (if approved)
- PubMed search: Vasopressin — NCBI PubMed
- PubMed Central search: Vasopressin — NCBI PMC
Reference
No ref on file.